Cannabinoids in Pediatric Medicine: Research and Clinical Insights
Cannabinoids for pediatric medicine have been studied in various medical conditions, with strongest evidence for refractory epilepsy. Current research highlights safety and efficacy concerns in pediatric care. Clinicians should use updated evidence to…
State Closes Another Watertown Smoke Shop Over Youth-Targeted Products
Illegal cannabis retail enforcement remains a critical issue as state agencies close shops selling products appealing to children. These enforcement actions highlight ongoing challenges in cannabis retail regulation. Clinicians should be aware of the…
Understanding Teens and Cannabis Use: Patterns and Risks
Adolescent cannabis use patterns vary widely and carry potential risks for brain development and mental health. Understanding these patterns helps clinicians provide better guidance. Routine screening and education are key to addressing teen cannabis use.
Is Today’s Marijuana More Dangerous Than We Realize—Especially for Teens?
Modern cannabis potency risks are increasingly concerning for adolescent brain development. Higher THC levels in today's cannabis may lead to psychiatric symptoms and cannabis use disorder in teens. Clinicians should counsel patients and families about…
Cannabinoids in Children: Medical Evidence Reviewed
Cannabinoids in pediatric medicine have been studied for various medical conditions with emerging clinical evidence. This review highlights safety and therapeutic applications in children. Clinicians must weigh benefits and risks carefully when…
Legal and Health Implications of Teen THC Crash Sentencing
This article discusses teen THC crash sentencing and the severe consequences of impaired driving among adolescents. It highlights the legal and health risks associated with cannabis use in young drivers. Clinicians should counsel teens on these dangers…
Teens’ Self-Reported Cannabis Use Linked to Increased Risk for New Psychiatric Diagnosis
This study highlights the association between adolescent cannabis use and new psychiatric diagnoses. The findings emphasize the need for screening cannabis use during adolescent mental health assessments. Understanding these risks is crucial for early…
Cannabinoid Drug Delivery Breakthroughs in Recent Research
This digest highlights cannabinoid drug delivery breakthroughs alongside key findings on liver disease and adolescent brain health. Advances in delivery technology improve cannabinoid bioavailability and therapeutic potential. Clinicians should consider…
Youth and Cannabis: Understanding the Risks to the Adolescent Brain
Cannabis use adolescent brain risks are a growing concern as legalization expands. Clinicians face challenges counseling youth due to variable product potency and incomplete data. Understanding these risks is crucial for adolescent health and safety.
Study: Adolescent Cannabis Use Doubles Psychotic and Bipolar Disorder Risk
Adolescent cannabis psychotic risk is significantly elevated, doubling the likelihood of psychotic and bipolar disorders. This study highlights the critical neurodevelopmental vulnerability during teenage years. Clinicians should prioritize screening and…
